Subscribe To
Processa pharmaceuticals to present pcs12852 gastroparesis results at the digestive disease week 2023 annual meeting
PCS12852 Shown to be Safe and Efficacious in Phase 2 Proof-of-Concept Trial in gastroparesis Patients P...
April 28, 2023, 12:15 pm
Processa pharmaceuticals to present pcs12852 gastroparesis results at the digestive disease week 2023 annual meeting
HANOVER, MD, April 28, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...
April 28, 2023, 8:15 am
Why are vanda pharma shares plunging today?
Vanda Pharmaceuticals Inc VNDA shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of ...
February 4, 2022, 8:34 am
Why are vanda pharma shares plunging today?
Vanda Pharmaceuticals Inc VNDA shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of ...
February 4, 2022, 8:34 am
Why are vanda pharma shares plunging today?
Vanda Pharmaceuticals Inc VNDA shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of ...
February 4, 2022, 8:34 am